Skip to main content

Research Repository

Advanced Search

Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors

Fu, Michael X.; Simmonds, Peter; Andreani, Julien; Baklan, Hatice; Webster, Mhairi; Asadi, Romisa; Golubchik, Tanya; Breuer, Judith; Ijaz, Samreen; Ushiro‐Lumb, Ines; Brailsford, Su; Irving, William L.; Andersson, Monique; Harvala, Heli

Authors

Michael X. Fu

Peter Simmonds

Julien Andreani

Hatice Baklan

Mhairi Webster

Romisa Asadi

Tanya Golubchik

Judith Breuer

Samreen Ijaz

Ines Ushiro‐Lumb

Su Brailsford

Monique Andersson

Heli Harvala



Abstract

Occult hepatitis B (HBV) infection (OBI), characterized by low viral loads, accounts for much of the risk of HBV transfusion-transmitted infection. With anticore antibodies (anti-HBc) screening introduced in England, the imperative to identify OBI donors has increased. We aimed to develop an ultra-sensitive PCR system and investigate risk factors for HBV DNA presence in blood donations. Seven extraction methods and three PCR assays were compared. The optimal system was sought to determine HBV DNA presence in anti-HBc-positive donations. Predictors of DNA positivity were subsequently investigated. Extraction from 5 mL of plasma increased sample representation and resulted in HBV DNA detection in low viral load samples (~0.5 IU/mL). Screening of 487 763 donations in 2022 identified two OBI donors and 2042 anti-HBc-positive donors, 412 of the latter with anti-HBs < 100 mIU/mL. Testing of 134 anti-HBc-positive donations utilizing the 5 mL extraction method identified two further HBV DNA-positive donations. Higher anti-HBc titer and anti-HBs negativity were significant predictors of DNA detectability in anti-HBc-positive donations. An ultrasensitive PCR assay identified potentially infectious donations increasing HBV DNA detection in anti-HBc-positive donors from 0.5% to 1.9%. Anti-HBc titers may further complement the risk stratification for DNA positivity in anti-HBc screening and minimize unnecessary donor deferral.

Journal Article Type Article
Acceptance Date Sep 21, 2023
Online Publication Date Oct 5, 2023
Publication Date 2023-10
Deposit Date Oct 23, 2023
Publicly Available Date Oct 24, 2023
Journal Journal of Medical Virology
Print ISSN 0146-6615
Electronic ISSN 1096-9071
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 95
Issue 10
Article Number e29144
DOI https://doi.org/10.1002/jmv.29144
Keywords Anti-HBc screening; HBV-ID-NAT; hepatitis B virus; occult HBV infection; predictive markers
Public URL https://nottingham-repository.worktribe.com/output/26262220
Publisher URL https://onlinelibrary.wiley.com/doi/10.1002/jmv.29144
Additional Information Received: 2023-05-10; Accepted: 2023-09-21; Published: 2023-10-05

Files





You might also like



Downloadable Citations